Genetic Technologies Limited announced that Chief Executive Officer, Ms. Alison Mew, has extended her personal leave until the end of March 2014. During this extended period of absence, the current management arrangements, as disclosed by the company on October 15, 2013, will be maintained. Mr. Tom Howitt will continue as Acting Chief Executive Officer supported by the Chairman and the Board.

The company look forward to Alison's return to the CEO role in April 2014.